These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 27409525

  • 1. Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicities.
    Brennan RC, Qaddoumi I, Billups CA, Kaluzny T, Furman WL, Wilson MW.
    Pediatr Blood Cancer; 2016 Nov; 63(11):1954-8. PubMed ID: 27409525
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.
    Sullivan EM, Wilson MW, Billups CA, Wu J, Merchant TE, Brennan RC, Haik BG, Shulkin B, Free TM, Given V, Rodriguez-Galindo C, Qaddoumi I.
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e335-40. PubMed ID: 24577551
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.
    Qaddoumi I, Billups CA, Tagen M, Stewart CF, Wu J, Helton K, McCarville MB, Merchant TE, Brennan R, Free TM, Given V, Haik BG, Rodriguez-Galindo C, Wilson MW.
    Cancer; 2012 Nov 15; 118(22):5663-70. PubMed ID: 22516936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug 15; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 8. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, Upadhyaya A, Azad R.
    Ophthalmology; 2016 Sep 15; 123(9):1933-9. PubMed ID: 27449712
    [Abstract] [Full Text] [Related]

  • 9. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, Lévy-Gabriel C, Brisse HJ, Desjardins L, Doz F.
    J Clin Oncol; 2013 Apr 10; 31(11):1458-63. PubMed ID: 23460706
    [Abstract] [Full Text] [Related]

  • 10. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.
    J Clin Oncol; 2003 May 15; 21(10):2019-25. PubMed ID: 12743157
    [Abstract] [Full Text] [Related]

  • 11. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan 15; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 12. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
    Wilson MW, Haik BG, Billups CA, Rodriguez-Galindo C.
    Ophthalmology; 2007 Nov 15; 114(11):2077-82. PubMed ID: 17628684
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interstitial deletion of 13q and a 13;X chromosome translocation results in partial trisomy 13 and bilateral retinoblastoma.
    Dries D, Baca K, Truss L, Dobin S.
    Ophthalmic Genet; 2003 Sep 15; 24(3):175-80. PubMed ID: 12868036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar 15; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 18. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct 15; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 19. Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
    Kim JH, Yu YS, Khwarg SI, Choi HS, Shin HY, Ahn HS.
    Korean J Ophthalmol; 2003 Jun 15; 17(1):35-43. PubMed ID: 12882506
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.